BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26479844)

  • 1. Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».
    Souayed N; Chennoufi M; Boughattas F; Haouas Z; Maaroufi K; Miled A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
    Chronobiol Int; 2015; 32(9):1201-10. PubMed ID: 26479844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective effect of isonicotinoylhydrazone SH7 against chronic isoniazid toxicity.
    Georgieva N; Gadjeva V; Tolekova A; Dimitrov D
    Pharmazie; 2005 Feb; 60(2):138-41. PubMed ID: 15739904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine and isoniazid induced liver toxicity and oxidative stress: Evaluation of mitigating properties of silibinin.
    Raghu R; Karthikeyan S
    Environ Toxicol Pharmacol; 2016 Sep; 46():217-226. PubMed ID: 27497728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin C on oxidative liver injury due to isoniazid in rats.
    Ergul Y; Erkan T; Uzun H; Genc H; Altug T; Erginoz E
    Pediatr Int; 2010 Feb; 52(1):69-74. PubMed ID: 19496975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.
    Saad EI; El-Gowilly SM; Sherhaa MO; Bistawroos AE
    Food Chem Toxicol; 2010 Jul; 48(7):1869-75. PubMed ID: 20417245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway.
    Jia ZL; Cen J; Wang JB; Zhang F; Xia Q; Wang X; Chen XQ; Wang RC; Hsiao CD; Liu KC; Zhang Y
    Chemosphere; 2019 Jul; 227():541-550. PubMed ID: 31004821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation of isoniazid pharmacokinetics in mice.
    Souayed N; Chennoufi M; Frej NB; Chaabane A; Ben-Attia M; Aouam K; Reinberg A; Boughattas NA
    Biomed Pharmacother; 2016 Dec; 84():1150-1155. PubMed ID: 27780145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian-time dependent tolerance and haematological toxicity to isoniazid in murine.
    Souayed N; Chennoufi M; Boughattas F; Hassine M; Ben Attia M; Aouam K; Reinberg A; Boughattas NA
    Biomed Pharmacother; 2015 Apr; 71():233-9. PubMed ID: 25960242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity mechanisms of isoniazid: A mini-review.
    Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
    J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by
    Ruan LY; Fan JT; Hong W; Zhao H; Li MH; Jiang L; Fu YH; Xing YX; Chen C; Wang JS
    Toxicol Lett; 2018 Oct; 295():256-269. PubMed ID: 29936297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.
    Attri S; Rana SV; Vaiphei K; Sodhi CP; Katyal R; Goel RC; Nain CK; Singh K
    Hum Exp Toxicol; 2000 Sep; 19(9):517-22. PubMed ID: 11204554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
    Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective and in vivo antioxidant activities of the hydroethanolic leaf extract of Mucuna pruriens (Fabaceae) in antitubercular drugs and alcohol models.
    Obogwu MB; Akindele AJ; Adeyemi OO
    Chin J Nat Med; 2014 Apr; 12(4):273-83. PubMed ID: 24863352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity of kaurene glycosides from Xanthium strumarium L. fruits in mice.
    Wang Y; Han T; Xue LM; Han P; Zhang QY; Huang BK; Zhang H; Ming QL; Peng W; Qin LP
    Pharmazie; 2011 Jun; 66(6):445-9. PubMed ID: 21699085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein protects against isoniazid-induced liver injury through the inhibition of CYP2E1-dependent oxidative and nitrosative impairment in mice.
    Lian Y; Zhao J; Wang YM; Zhao J; Peng SQ
    Food Chem Toxicol; 2017 Apr; 102():32-38. PubMed ID: 28126494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide exposure augments isoniazide-induced liver injury.
    Su Y; Zhang Y; Chen M; Jiang Z; Sun L; Wang T; Zhang L
    J Appl Toxicol; 2014 Dec; 34(12):1436-42. PubMed ID: 25331106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diosbulbin B-induced liver injury in mice and its mechanism.
    Ma Y; Niu C; Wang J; Ji L; Wang Z
    Hum Exp Toxicol; 2014 Jul; 33(7):729-36. PubMed ID: 24107456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance.
    Mann A; Pelz T; Rennert K; Mosig A; Decker M; Lupp A
    Hum Cell; 2017 Oct; 30(4):267-278. PubMed ID: 28527127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.
    Enriquez-Cortina C; Almonte-Becerril M; Clavijo-Cornejo D; Palestino-Domínguez M; Bello-Monroy O; Nuño N; López A; Bucio L; Souza V; Hernández-Pando R; Muñoz L; Gutiérrez-Ruiz MC; Gómez-Quiroz LE
    Toxicol Sci; 2013 Sep; 135(1):26-36. PubMed ID: 23764483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.